Kramer-Hämmerle Susanne, Ceccherini-Silberstein Francesca, Bickel Christian, Wolff Horst, Vincendeau Michelle, Werner Thomas, Erfle Volker, Brack-Werner Ruth
Institute of Molecular Virology, GSF-National Research Center for Environment and Health, Ingolstädter Landstrasse 1, D-85764 Neuherberg, Germany.
BMC Cell Biol. 2005 Apr 24;6(1):20. doi: 10.1186/1471-2121-6-20.
Human cell types respond differently to infection by human immunodeficiency virus (HIV). Defining specific interactions between host cells and viral proteins is essential in understanding how viruses exploit cellular functions and the innate strategies underlying cellular control of HIV replication. The HIV Rev protein is a post-transcriptional inducer of HIV gene expression and an important target for interaction with cellular proteins. Identification of Rev-modulating cellular factors may eventually contribute to the design of novel antiviral therapies.
Yeast-two hybrid screening of a T-cell cDNA library with Rev as bait led to isolation of a novel human cDNA product (16.4.1). 16.4.1-containing fusion proteins showed predominant cytoplasmic localization, which was dependent on CRM1-mediated export from the nucleus. Nuclear export activity of 16.4.1 was mapped to a 60 amino acid region and a novel transport signal identified. Interaction of 16.4.1 with Rev in human cells was shown in a mammalian two-hybrid assay and by colocalization of Rev and 16.4.1 in nucleoli, indicating that Rev can recruit 16.4.1 to the nucleus/nucleoli. Rev-dependent reporter expression was inhibited by overexpressing 16.4.1 and stimulated by siRNAs targeted to 16.4.1 sequences, demonstrating that 16.4.1 expression influences the transactivation function of Rev.
These results suggest that 16.4.1 may act as a modulator of Rev activity. The experimental strategies outlined in this study are applicable to the identification and biological characterization of further novel Rev-interacting cellular factors.
人类细胞类型对人类免疫缺陷病毒(HIV)感染的反应各不相同。确定宿主细胞与病毒蛋白之间的特定相互作用对于理解病毒如何利用细胞功能以及细胞控制HIV复制的内在策略至关重要。HIV Rev蛋白是HIV基因表达的转录后诱导剂,也是与细胞蛋白相互作用的重要靶点。鉴定调节Rev的细胞因子最终可能有助于设计新型抗病毒疗法。
以Rev为诱饵对T细胞cDNA文库进行酵母双杂交筛选,分离出一种新型人类cDNA产物(16.4.1)。含16.4.1的融合蛋白主要定位于细胞质,这依赖于CRM1介导的从细胞核输出。16.4.1的核输出活性定位于一个60个氨基酸的区域,并鉴定出一种新型转运信号。在哺乳动物双杂交试验中以及通过Rev和16.4.1在核仁中的共定位,显示了16.4.1与人类细胞中Rev的相互作用,表明Rev可以将16.4.1招募到细胞核/核仁。过表达16.4.1可抑制Rev依赖的报告基因表达,而靶向16.4.1序列的小干扰RNA可刺激该表达,这表明16.4.1的表达影响Rev的反式激活功能。
这些结果表明16.4.1可能作为Rev活性的调节剂。本研究中概述的实验策略适用于进一步鉴定和生物学表征与Rev相互作用的新型细胞因子。